Radiopharmaceuticals: state of the art
- 1 June 1990
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 17 (6-8), 346-364
- https://doi.org/10.1007/bf01268027
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- 99mTc-human immunoglobulin (HIG) — first results of a new agent for the localization of infection and inflammationEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- A new method for protein labeling with 99mTcInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1989
- Synthesis and in vivo testing of a bromobutyl substituted 1,2-dithia-5,9-diazacycloundecane: a versatile precursor for new 99mTc-bis(aminoethanethiol) complexesInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1989
- 99Tcm sestamibi — a new agent for parathyroid imagingNuclear Medicine Communications, 1989
- The future of PET?Nuclear Medicine Communications, 1989
- Pharmacokinetics of 99MTC‐myocardial perfusion agents in different speciesJournal of Labelled Compounds and Radiopharmaceuticals, 1989
- Use of sodium iodide to overcome the eluate age restriction for Ceretec(tm) reconstitutionNuclear Medicine Communications, 1989
- Preparation and biodistribution of [125I]IBZM: A potential CNS D-2 dopamine receptor imaging agentInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
- Treatment of metastatic bone pain with strontium-89International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
- A definition of substrate specificity in renal transport of organic anionsJournal of Theoretical Biology, 1965